Metastatic Neoplasms to the Oral Cavity Clinical Presentation

  • Author: Abraham Hirshberg, MD, DMD; Chief Editor: William D James, MD   more...
 
Updated: May 8, 2012
 

History

Symptoms develop in a relatively short period. Note the following:

  • In the oral soft tissues, most patients report a lump.
  • In the jawbones, swelling, pain, and paresthesia of the affected nerve are the chief reported symptoms.
  • Give special attention to patients with numb chin syndrome or mental nerve neuropathy. The numb chin syndrome is the consequence of loss of function of the terminal sensory division of the mandibular branch of the trigeminal nerve. Any pathological process involving the mental nerve, the mandibular nerve, and even the mandibular trunk of the fifth nerve may produce this loss of function. The appearance of a mental nerve neuropathy should always raise the possibility of a metastatic disease in the mandible.[18]
  • With the progression of the disease, oral metastatic lesions (especially those in soft tissues) cause progressive discomfort. Pain, bleeding, superinfection, dysphagia, interference with mastication, and disfigurement are some of the main reported symptoms.
  • In some cases, the metastasis is discovered in a recent extraction site. The main symptom is a soft tissue mass extruding from a recent extraction wound and accompanied by pain. In many of these cases, the metastatic tumor is present in the area before the extraction; it can cause pain, swelling, and loosening of the teeth. These symptoms lead to the extraction of the affected tooth. In some cases, metastasis probably develops after extraction. Tooth extraction can serve as a promoting factor in the metastatic process.
Next

Physical

The clinical presentation of the metastatic tumors differs among the various oral sites, as follows:

  • In the oral soft tissues, the attached gingiva is the most commonly affected site, followed by the tongue and, with much less frequency, the remaining mucosa.
  • The presence of teeth seems to have a crucial effect on the oral site preference of metastases. In the dentulous patient, about 80% have metastasis in the attached gingiva. In the edentulous patient, metastatic lesions are distributed equally between the tongue and alveolar mucosa.
  • In the jawbones, the common location of the metastatic lesion is the mandible; the molar area is the most frequently involved site.
  • In its early manifestation, gingival metastasis resembles hyperplastic or reactive lesions (eg, pyogenic granuloma, peripheral giant cell granuloma, fibrous epulis),[19] as shown in the images below. A large pedunculated mass on the gingiva resemblesA large pedunculated mass on the gingiva resembles a pyogenic granuloma and peripheral giant cell granuloma in a 44-year-old woman with metastatic breast carcinoma. A large soft-tissue mass on the gingiva resembles A large soft-tissue mass on the gingiva resembles pyogenic granuloma and peripheral giant cell granuloma in a 51-year-old man with metastatic renal cell carcinoma.
  • In other oral soft tissue locations, especially in the tongue, the metastatic lesion manifests as a submucosal mass.
  • In the jawbones, physical examination reveals a bony swelling with tenderness over the affected area.
  • Sometimes, tooth mobility and trismus are present.
Previous
Next

Causes

The oral region is an uncommon site for metastatic lesions. However, several factors can enhance metastatic colonization in the oral region. Note the following:

  • In dentulous patients, 80% of the metastatic tumors to the oral soft mucosa are found in the attached gingiva, whereas in edentulous patients, metastatic lesions are equally distributed between the tongue and the alveolar mucosa. The rich capillary network of chronically inflamed gingiva has been suggested as a mechanism that entraps malignant cells.
  • The jawbones have little active marrow, which is a preferred site for metastatic deposits in the skeleton. However, in some cases, active marrow can be found in the posterior area of the mandible. In addition, remnants of hematopoietic marrow can be found in an edentulous jaw in cases of focal osteoporotic bone marrow defects. These hematopoietically active sites may attract metastatic tumor cells.
Previous
 
 
Contributor Information and Disclosures
Author

Abraham Hirshberg, MD, DMD  Associate Professor, Department of Oral Pathology and Oral Medicine, School of Dental Medicine, Tel Aviv University, Israel

Abraham Hirshberg, MD, DMD is a member of the following medical societies: American Academy of Oral and Maxillofacial Pathology, International Association for Dental Research, and International Association of Oral Pathologists

Disclosure: Nothing to disclose.

Coauthor(s)

Amos Buchner, DMD, MSD  Professor Emeritus, Department of Oral Pathology and Oral Medicine, Tel Aviv University School of Dental Medicine, Israel

Amos Buchner, DMD, MSD is a member of the following medical societies: American Academy of Oral and Maxillofacial Pathology, American Academy of Oral Medicine, International Association for Dental Research, and International Association of Oral Pathologists

Disclosure: Nothing to disclose.

Specialty Editor Board

Sungnack Lee, MD  Vice President of Medical Affairs, Professor, Department of Dermatology, Ajou University School of Medicine, Korea

Sungnack Lee, MD is a member of the following medical societies: American Dermatological Association

Disclosure: Nothing to disclose.

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Drore Eisen, MD, DDS  Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati

Drore Eisen, MD, DDS is a member of the following medical societies: American Academy of Dermatology, American Academy of Oral Medicine, and American Dental Association

Disclosure: Nothing to disclose.

Glen H Crawford, MD  Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital

Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons

Disclosure: Nothing to disclose.

Chief Editor

William D James, MD  Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology

Disclosure: Elsevier Royalty Other

References
  1. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. Oct 14 2011;147(2):275-92. [Medline].

  2. Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. Apr 2009;9(4):274-84. [Medline].

  3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. Mar 4 2011;144(5):646-74. [Medline].

  4. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. Apr 2009;9(4):239-52. [Medline].

  5. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. Nov 25 2009;139(5):871-90. [Medline].

  6. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. Apr 2 2010;141(1):52-67. [Medline].

  7. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. Dec 2002;29(6 Suppl 16):15-8. [Medline].

  8. Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17(11):1359-70. [Medline].

  9. Bishop-Bailey D. Tumour vascularisation: a druggable target. Curr Opin Pharmacol. Apr 2009;9(2):96-101. [Medline].

  10. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. Jun 2003;9(6):677-84. [Medline].

  11. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. Jul 2004;4(7):540-50. [Medline].

  12. van der Waal RI, Buter J, van der Waal I. Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg. Feb 2003;41(1):3-6. [Medline].

  13. Hirshberg A, Leibovich P, Buchner A. Metastases to the oral mucosa: analysis of 157 cases. J Oral Pathol Med. Oct 1993;22(9):385-90. [Medline].

  14. Hirshberg A, Leibovich P, Buchner A. Metastatic tumors to the jawbones: analysis of 390 cases. J Oral Pathol Med. Sep 1994;23(8):337-41. [Medline].

  15. Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity - pathogenesis and analysis of 673 cases. Oral Oncol. Aug 2008;44(8):743-52. [Medline].

  16. Zhang FG, Hua CG, Shen ML, Tang XF. Primary tumor prevalence has an impact on the constituent ratio of metastases to the jaw but not on metastatic sites. Int J Oral Sci. Jul 2011;3(3):141-52. [Medline].

  17. Shen ML, Kang J, Wen YL, Ying WM, Yi J, Hua CG. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature. J Oral Maxillofac Surg. Apr 2009;67(4):718-37. [Medline].

  18. Laurencet FM, Anchisi S, Tullen E, Dietrich PY. Mental neuropathy: report of five cases and review of the literature. Crit Rev Oncol Hematol. Apr 2000;34(1):71-9. [Medline].

  19. Seoane J, Van der Waal I, Van der Waal RI, Cameselle-Teijeiro J, Antón I, Tardio A. Metastatic tumours to the oral cavity: a survival study with a special focus on gingival metastases. J Clin Periodontol. Jun 2009;36(6):488-92. [Medline].

  20. Smith SF, Blackman G, Hopper C. Numb chin syndrome: a nonmetastatic neurological manifestation of malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Mar 2008;105(3):e53-6. [Medline].

  21. Logothetis CJ, Lin SH. Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer. Jan 2005;5(1):21-8. [Medline].

  22. Natoli C, Ramazzotti V, Nappi O, Giacomini P, Palmeri S, Salvatore M. Unknown primary tumors. Biochim Biophys Acta. Aug 2011;1816(1):13-24. [Medline].

  23. Monzon FA, Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch Pathol Lab Med. Feb 2010;134(2):216-24. [Medline].

  24. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. Apr 2008;26(4):462-9. [Medline].

  25. Marchevsky AM, Gupta R, Balzer B. Diagnosis of metastatic neoplasms: a clinicopathologic and morphologic approach. Arch Pathol Lab Med. Feb 2010;134(2):194-206. [Medline].

  26. Krishna M. Diagnosis of metastatic neoplasms: an immunohistochemical approach. Arch Pathol Lab Med. Feb 2010;134(2):207-15. [Medline].

Previous
Next
 
A large pedunculated mass on the gingiva resembles a pyogenic granuloma and peripheral giant cell granuloma in a 44-year-old woman with metastatic breast carcinoma.
A large soft-tissue mass on the gingiva resembles pyogenic granuloma and peripheral giant cell granuloma in a 51-year-old man with metastatic renal cell carcinoma.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.